BIOTALYS NV (BTLS.BR) Stock Price & Overview

EBR:BTLS • BE0974386188

Current stock price

1.75 EUR
-0.07 (-3.85%)
Last:

The current stock price of BTLS.BR is 1.75 EUR. Today BTLS.BR is down by -3.85%. In the past month the price decreased by -33.96%. In the past year, price decreased by -49.57%.

BTLS.BR Key Statistics

52-Week Range1.56 - 5.5
Current BTLS.BR stock price positioned within its 52-week range.
1-Month Range1.56 - 2.7
Current BTLS.BR stock price positioned within its 1-month range.
Market Cap
65.748M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.41
Dividend Yield
N/A

BTLS.BR Stock Performance

Today
-3.85%
1 Week
+2.04%
1 Month
-33.96%
3 Months
-48.68%
Longer-term
6 Months -61.11%
1 Year -49.57%
2 Years -43.18%
3 Years -71.50%
5 Years N/A
10 Years N/A

BTLS.BR Stock Chart

BIOTALYS NV / BTLS Daily stock chart

BTLS.BR Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to BTLS.BR. When comparing the yearly performance of all stocks, BTLS.BR is a bad performer in the overall market: 98.1% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

BTLS.BR Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to BTLS.BR. The financial health of BTLS.BR is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BTLS.BR Earnings

Next Earnings DateMar 27, 2026
Last Earnings DateN/A
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

BTLS.BR Forecast & Estimates

9 analysts have analysed BTLS.BR and the average price target is 7.21 EUR. This implies a price increase of 311.89% is expected in the next year compared to the current price of 1.75.

For the next year, analysts expect an EPS growth of 1.76% and a revenue growth -52% for BTLS.BR


Analysts
Analysts84.44
Price Target7.21 (312%)
EPS Next Y1.76%
Revenue Next Year-52%

BTLS.BR Groups

Sector & Classification

Index Membership

BTLS.BR Financial Highlights

Over the last trailing twelve months BTLS.BR reported a non-GAAP Earnings per Share(EPS) of -0.41. The EPS increased by 19.48% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-14.83M
Industry RankSector Rank
PM (TTM) N/A
ROA -51.18%
ROE -74.88%
Debt/Equity 0.16
Chartmill High Growth Momentum
EPS Q2Q%-7.58%
Sales Q2Q%N/A
EPS 1Y (TTM)19.48%
Revenue 1Y (TTM)N/A

BTLS.BR Ownership

Ownership
Inst Owners21.54%
Shares37.57M
Float19.64M
Ins Owners4.83%
Short Float %N/A
Short RatioN/A

About BTLS.BR

Company Profile

BTLS logo image Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.

Company Info

IPO: 2021-07-02

BIOTALYS NV

Buchtenstraat 11

Ghent OOST-VLAANDEREN BE

Employees: 63

BTLS Company Website

BTLS Investor Relations

Phone: 3292745400

BIOTALYS NV / BTLS.BR FAQ

What does BIOTALYS NV do?

Biotalys NV engages in the development of sustainable crop protection products. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 63 full-time employees. The company went IPO on 2021-07-02. AGROBODY Foundry is a product of this company that provides crop protection products, based on active ingredients in combination with Agrobodies as formulation agents. The company develops technology for sustainable crop protection. The company offers tools to prevent crop loss while extending post-harvest protection and reducing food waste. This company provides protein-based biocontrol solutions. Biotalys allows biocontrol solutions to tackle a wide range of crop pests and diseases. This company has built a product pipeline against key pests and diseases known as EvocaTM. The company also has a range of products pipeline of BioFungicides, BioInsecticides and BioBactericides.


Can you provide the latest stock price for BIOTALYS NV?

The current stock price of BTLS.BR is 1.75 EUR. The price decreased by -3.85% in the last trading session.


Does BIOTALYS NV pay dividends?

BTLS.BR does not pay a dividend.


What is the ChartMill technical and fundamental rating of BTLS stock?

BTLS.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


How is the market expecting BTLS stock to perform?

9 analysts have analysed BTLS.BR and the average price target is 7.21 EUR. This implies a price increase of 311.89% is expected in the next year compared to the current price of 1.75.


Can you provide the upcoming earnings date for BIOTALYS NV?

BIOTALYS NV (BTLS.BR) will report earnings on 2026-03-27, after the market close.


What is the ownership structure of BIOTALYS NV (BTLS.BR)?

You can find the ownership structure of BIOTALYS NV (BTLS.BR) on the Ownership tab.